Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05149365
What this trial is testing

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Who this might be right for
Acute-graft-versus-host DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 190
Very early researchLooking for participantsNCT06735690
What this trial is testing

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
City of Hope Medical Center 15
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Not applicableStudy completedNCT05515497
What this trial is testing

BMT4me: Post-HSCT Medication Adherence mHealth App

Who this might be right for
Stem Cell TransplantAdherence, MedicationDigital Health
Micah Skeens 50
Not applicableUnknownNCT00563108
What this trial is testing

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 60
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Testing effectiveness (Phase 2)Study completedNCT03339297
What this trial is testing

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Who this might be right for
Graft-versus-host DiseaseAcute-graft-versus-host Disease
Jazz Pharmaceuticals 152
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT01812720
What this trial is testing

Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Not applicableStudy completedNCT03233659
What this trial is testing

Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell TransplantationGVHD
IRCCS Azienda Ospedaliero-Universitaria di Bologna 177
Testing effectiveness (Phase 2)Study completedNCT00702403
What this trial is testing

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06199427
What this trial is testing

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Who this might be right for
Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Not applicableStudy completedNCT02867891
What this trial is testing

Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial

Who this might be right for
Acute Myeloid Leukemia
Robert Zeiser 396
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07737262
What this trial is testing

Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients

Who this might be right for
Aplastic Anemia
Peking University People's Hospital 142
Not applicableEnded earlyNCT03752372
What this trial is testing

Microbiome Alterations in IL10RA-deficient Patients After HSCT

Who this might be right for
Inflammatory Bowel DiseasesMicrobiota
Children's Hospital of Fudan University 13
Next Page
35